DC4U Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
DC4U General Information
Description
Developer of immunotherapy intended to cure allergies and autoimmune diseases. The company utilizes its proprietary technology to develop drugs and medical systems that help patients cope with various allergies by effectively modulating the human immune response, either boosting or suppressing the immune system, enabling users to lead normal lives.
Contact Information
Website
www.dc4u-technologies.nlCorporate Office
- Hollandse Kade 32
- 1391 JM Abcoude
- Netherlands
Corporate Office
- Hollandse Kade 32
- 1391 JM Abcoude
- Netherlands
DC4U Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 06-Jan-2026 | Completed | Out of Business | |||
| 6. Grant | 25-Oct-2022 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 31-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 31-Aug-2017 | Completed | Product In Beta Test | |||
| 3. Grant | 01-Dec-2016 | Completed | Product In Beta Test | |||
| 2. Later Stage VC | Completed | Product In Beta Test | ||||
| 1. Grant | 01-Jul-2009 | $3.5M | Completed | Product In Beta Test |
DC4U Signals
DC4U FAQs
-
When was DC4U founded?
DC4U was founded in 2006.
-
Where is DC4U headquartered?
DC4U is headquartered in Abcoude, Netherlands.
-
What is the size of DC4U?
DC4U has 2 total employees.
-
What industry is DC4U in?
DC4U’s primary industry is Drug Discovery.
-
Is DC4U a private or public company?
DC4U is a Private company.
-
What is DC4U’s current revenue?
The current revenue for DC4U is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process